Analyst Price Targets — DH
| Date | Analyst | Firm | Target | Price @ Post | Source | Headline |
|---|---|---|---|---|---|---|
| December 18, 2025 12:52 pm | Craig Hettenbach | Morgan Stanley | $3.50 | $2.28 | TheFly | Definitive Healthcare price target lowered to $3.50 from $5 at Morgan Stanley |
| December 8, 2025 9:13 pm | — | Barclays | $2.75 | $2.45 | TheFly | Definitive Healthcare price target lowered to $2.75 from $3 at Barclays |
| August 8, 2025 2:15 pm | Joe Vruwink | Robert W. Baird | $4.00 | $3.86 | TheFly | Definitive Healthcare price target raised to $4 from $3 at Baird |
| September 17, 2024 5:33 am | David Larsen | BTIG | $7.00 | $4.44 | TheFly | Definitive Healthcare initiated with a Buy at BTIG |
| August 9, 2024 9:46 am | George Hill | Deutsche Bank | $5.00 | $3.87 | TheFly | Definitive Healthcare price target lowered to $5 from $7 at Deutsche Bank |
| August 7, 2024 5:23 am | Saket Kalia | Barclays | $4.00 | $3.65 | TheFly | Definitive Healthcare price target lowered to $4 from $6 at Barclays |
| August 6, 2024 9:17 am | Craig Hettenbach | Morgan Stanley | $5.00 | $3.72 | TheFly | Definitive Healthcare price target lowered to $5 from $9 at Morgan Stanley |
| August 5, 2024 2:05 pm | Kash Rangan | Goldman Sachs | $8.00 | $3.55 | StreetInsider | Definitive Healthcare Corp (DH) PT Lowered to $8 at Goldman Sachs |
| July 31, 2024 9:21 am | David Grossman | Stifel Nicolaus | $7.50 | $3.41 | TheFly | Definitive Healthcare price target lowered to $7.50 from $9.50 at Stifel |
| May 9, 2024 4:58 am | Saket Kalia | Barclays | $7.00 | $5.35 | TheFly | Definitive Healthcare price target lowered to $7 from $11 at Barclays |
Latest News for DH
Definitive Healthcare Corp. (DH) Q4 2025 Earnings Call Transcript
Definitive Healthcare Corp. (NASDAQ: DH - Get Free Report) has earned an average recommendation of "Hold" from the eight ratings firms that are covering the stock, Marketbeat.com reports. Three analysts have rated the stock with a sell recommendation, three have issued a hold recommendation, one has issued a buy recommendation and one has assigned a strong
Definitive Healthcare Corp. (DH) came out with quarterly earnings of $0.06 per share, in line with the Zacks Consensus Estimate . This compares to earnings of $0.08 per share a year ago.
FRAMINGHAM, Mass., Feb. 26, 2026 (GLOBE NEWSWIRE) -- Definitive Healthcare Corp. (“Definitive Healthcare” or the “Company”) (Nasdaq: DH), an industry leader in healthcare market data and analytics, today announced financial results for the quarter and full year ended December 31, 2025.
Definitive Healthcare (NASDAQ: DH - Get Free Report) will likely be issuing its Q4 2025 results after the market closes on Thursday, February 26th. Analysts expect the company to announce earnings of $0.06 per share and revenue of $59.5660 million for the quarter. Interested persons can check the company's upcoming Q4 2025 earning summary page for
🧮 Earnings Move Analyzer
Insider Trading
Insider Trading
| Name | Role | Date | Type | Shares | Price | Form | Link |
|---|
Senate Trading
No Senate trades found for DH.
U.S. House Trading
No House trades found for DH.
Options Chain
Select an expiration to expand. Bid/Ask are shown first (before Mark) on both sides.